Looking Beyond Ldl-C To Address Ascvd Risk

Looking Beyond LDL-C to Address ASCVD Risk

Cardiometabolic Health Congress (CMHC)

Beyond LDL: Assessing and Treating Residual ASCVD Risk | Marc-Andre Cornier, MD

University of Colorado | Department of Medicine

Beyond LDL-C: Atherogenic Lipoproteins and CVD Risk

Yale Cardiovascular Medicine Grand Rounds

Patient Perspective: Managing LDL-C to Reduce ASCVD Risk

Cardiometabolic Health Congress (CMHC)

Looking Beyond LDL to Reduce Cardiovascular Events

Triglycerides and Cardiovascular Risk Beyond LDL-C

Dr. Payal Kohli, MD

Innovative Lipid Management Strategies for ASCVD Risk Reduction

American Heart Association

Dyslipidemia Management & ASCVD Risk Reduction

Cardiometabolic Health Congress (CMHC)

Blood Lipids and Cardiovascular Risk: Everything You Need to Know

Nourished by Science

LDL Cholesterol level: Your lab results explained

Nutrition Made Simple!

LDL-C Cumulative exposure hypothesis of ASCVD

Practical Insights of Cholesterol Guidelines for Secondary Prevention of ASCVD

American Heart Association

Dr Aruna Pradhan - Have we reached the limits of lipid lowering? What next? - Full version

At the Limits - Leading Medical Education

LDL Cholesterol Lowering and CV Risk

The Truth About Dietary Cholesterol | Dr. Peter Attia & Dr. Andrew Huberman

Huberman Lab Clips

Lessons From an Academic Perspective - Sharing Ownership of Reducing ASCVD Risk

American Heart Association

Cholesterol, especially LDL-C causes ASCVD

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Lp(a) and ASCVD Risk – Hope of the new therapy

Cardiology University of Washington

Update on ASCVD Risk Assessment and Management

Yale Cardiovascular Medicine Grand Rounds